Back to ABT overview

ABT Abbott Laboratories PE ratio, current and historical analysis

The current PE ratio for Abbott Laboratories stock as of Jun 14, 2024 is 32.1. This is calculated based on the current EPS of $3.23 and the stock price of $103.68 per share. The P/E ratio has a decrease of 7% from the past four quarters average of 34.6.

ABT PE ratio history

How has ABT's PE ratio performed in the past

The average historical PE ratio of Abbott Laboratories for the last ten years is 49.81. The current PE ratio of 32.1 is 36% below the historical average. Over the past ten years, ABT's PE ratio was at its highest in the Mar 2018 quarter at 230.46, when the stock price was $59.92 and the EPS was $0.26. The lowest value was in the Sep 2015 quarter, when it reached 13.27 with a price of $40.22 and an EPS of $3.03.

Average
49.81
Median
36.21
Minimum
13.27
Maximum
230.46

Abbott Laboratories PE ratio by year

Maximum annual increase: 417.3% in 2017

Maximum annual decrease: -74.46% in 2018

Year PE ratio Change
2023 33.56 20.42%
2022 27.87 -21.38%
2021 35.45 -18.41%
2020 43.45 3.55%
2019 41.96 -22.27%
2018 53.98 -74.46%
2017 211.37 417.3%
2016 40.86 167.41%
2015 15.28 -49.08%
2014 30.01 28.41%

ABT average PE ratio chart

What is the average PE ratio of ABT for the past years

ABT's current P/E ratio is above the 3-year historical average, but it is below the 5 and 10-year averages.

3-year avg
30.45
5-year avg
36.65
10-year avg
49.81
15-year avg
38.81

ABT PE vs peers

What is ABT's PE ratio compared to its peers

Compared to its peers AZN and TMO, ABT's PE ratio stands lower, however it is higher than JNJ's and NVS's. Abbott Laboratories's current PE ratio of 32.1 is comparable to the average of its peer group, which is 32.22.

Stock name PE ratio Market cap
JNJ Johnson & Johnson 9.54 $350.27B
NVS Novartis AG 14.27 $215.71B
MDT Medtronic plc 25.73 $107.61B
ABT Abbott Laboratories 32.1 $180.37B
TMO Thermo Fisher Scientific Inc 36.55 $218.36B
HOLX Hologic Inc 36.63 $16.75B
AZN Astrazeneca plc 38.82 $246.75B
BSX Boston Scientific Corp 63.97 $112.85B
PFE Pfizer Inc N/A $156B
BMY Bristol Myers Squibb Co N/A $83.52B

Frequently asked questions

What is Abbott Laboratories's PE ratio?

As of Jun 14, 2024, ABT stock has a price to earnings ratio of 32.1.

What is the 3-year average PE ratio for Abbott Laboratories (ABT)?

The average PE ratio for ABT stock over the past 3 years is 30.45.

What is the 5-year average PE ratio for Abbott Laboratories (ABT)?

The average PE ratio for ABT stock over the past 5 years is 36.65.

What is the highest PE ratio for ABT?

Over the last ten years, the quarterly PE ratio reached a historic high of 230.46 in the Mar 2018 quarter.

How does the current PE ratio for ABT compare to its historical average?

The current price to earnings ratio of ABT is 36% lower than the 10-year historical average.

How is ABT's PE ratio calculated (Abbott Laboratories PE ratio formula)?

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 14, 2024), Abbott Laboratories's stock price is $103.68. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $3.23. Therefore, Abbott Laboratories's P/E ratio for today is 32.1. PE RATIO(32.1) = STOCK PRICE($103.68) / TTM EPS($3.23)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.